Current Opinion in Immunology

Papers
(The median citation count of Current Opinion in Immunology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection279
An easy pill to swallow: oral recombinant vaccines for the 21st century98
Mechanistic insights into epigenetic contributions to psoriasis pathogenesis and their clinical implications93
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity85
Principles and practical applications of structure-based vaccine design74
Oncogenic viruses, cancer biology, and innate immunity71
TAP-ing into the cross-presentation secrets of dendritic cells68
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy68
The future of vaccination in Latin America: learning from the COVID-19 pandemic67
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation60
Can juvenile idiopathic arthritis be cured?60
Mycobacterial diseases in patients with inborn errors of immunity60
Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs57
Host genetics of innate immune system in infection53
Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity51
Safety switches for adoptive cell therapy49
Beyond the gastric epithelium — the paradox of Helicobacter pylori-induced immune responses48
Innate antiviral immunity and immunometabolism in hepatocytes46
Commander-in-chief: monocytes rally the troops for defense against aspergillosis44
Some thoughts about what non-mammalian jawed vertebrates are telling us about antigen processing and peptide loading of MHC molecules44
Can we cure Behçet syndrome?44
Complement in antiphospholipid syndrome, time to target?42
Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models42
B cell–targeted therapies in autoimmune skin disease: current advances and challenges42
Can sarcoidosis be cured?42
Regulation of MHC class II and CD86 expression by March-I in immunity and disease41
Necroptosis in immunity, tissue homeostasis, and cancer40
Nutritional modulation of antitumor immunity40
Metabolism and macrophages in the tumor microenvironment40
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune tolerance39
Immunological lessons from genome-wide association studies of infections39
Animal models of autoimmune encephalitis38
Mapping and modelling human B cell maturation in the germinal centre32
Can we cure bullous skin diseases?32
Patterns of bacterial viability governing noncanonical inflammasome activation30
Antibody glycosylation directs innate and adaptive immune collaboration29
Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation29
Implication of epigenetic factors in development and recurrence of psoriasis28
Immunological scars after cure of hepatitis C virus infection: Long‐HepC?27
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation26
T follicular helper cells and their impact on humoral responses during pathogen and vaccine challenge26
Signals governing monocyte differentiation during inflammation26
Human MALT1 deficiency and predisposition to infections26
Can we cure antiphospholipid syndrome?25
Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy25
Editorial overview: Recent advances in research of IgE-mediated and IgE-independent allergies, an overview25
Resolving adjuvant mode of action to enhance vaccine efficacy25
Editorial Board25
Outer membrane vesicle-based intranasal vaccines24
Thetis cells: regulators of intestinal immune tolerance24
Harnessing IgG Fc glycosylation for clinical benefit23
Game of Omes: ribosome profiling expands the MHC-I immunopeptidome23
Immune responses to Toxoplasma gondii23
Nucleic acid triggers of autoimmunity and autoinflammation23
The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention23
Editorial Board22
Bidirectional sensory neuron–immune interactions: a new vision in the understanding of allergic inflammation22
HLA-B27 as a potential target for the cure of axial spondyloarthritis21
B cell memory of Immunoglobulin E (IgE) antibody responses in allergy21
Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans21
Epigenetics: the link between environmental exposures and autoimmune diseases20
cGAS-like receptor-mediated immunity: the insect perspective20
Intracellular complement in monocytes and macrophages: emerging roles20
Rheumatoid arthritis — the role of T cells in this complex systemic autoimmune disease20
Inborn errors of human transcription factors governing IFN-γ antimycobacterial immunity20
Killing in self-defense: proapoptotic drugs to eliminate intracellular pathogens20
New insights into the mechanisms regulating plasma cell survival and longevity20
Inborn errors of autophagy and infectious diseases19
Neuroimmune crosstalk in the skin: a delicate balance governing inflammatory processes18
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment18
‘Can we cure IgG4-related diseases?’18
Tumor immune evasion through loss of MHC class-I antigen presentation17
The role of CD4 T cells in rejection of solid tumors17
Drivers and shapers of macrophages specification in the developing brain17
Regulation of inflammation by Interleukin-10 in the intestinal and respiratory mucosa17
Can we cure lupus?17
Regulation of type I and type III interferon induction in response to pathogen sensing17
Mechanisms and risk factors for perinatal allergic disease17
The role of epigenetic modifications in systemic autoinflammatory diseases16
Innate control of adaptive immunity and adaptive instruction of innate immunity: bi-directional flow of information16
Immunometabolic regulation of germinal centers and its implications for aging16
Publisher's Note16
New insights and approaches for analyses of immunopeptidomes16
Intrinsic and extrinsic regulation of IgE B cell responses15
Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells15
Eliciting or silencing complement activation: strategies for optimizing monoclonal antibodies functions15
Red blood cell alloimmunization immunogenetic risk factor15
Advances and challenges in investigating B-cells via single-cell transcriptomics15
TH17 cell immune adaptation15
IFNε, IFNω and IFNλ: interferons defending the mucosa15
The role of epigenetics in inflammatory memory15
ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency15
HyperIgE in hypomorphic recombination-activating gene defects14
Monogenic susceptibility to live viral vaccines14
PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis14
Functional flexibility and plasticity in immune control of systemic Salmonella infection14
Differential signaling by type-I and type-III interferons in mucosa14
Defining the niche for stem-like CD8+ T cell formation and function14
The thymoproteasome in shaping the CD8+ T-cell repertoire14
Inherited human ZNF341 deficiency13
Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections13
Infections in the monogenic autoimmune syndrome APECED13
Inflammasomes and their role in PANoptosomes13
T follicular helper cells in food allergy13
Microbiota and B-1 B cell repertoire development in mice13
Editorial overview: Tumour immunology: Engineered T cell therapy of cancer: current success and future improvements13
The choroid plexus in inflammatory and degenerative diseases of the central nervous system13
Curing inflammatory bowel diseases: breaking the barriers of current therapies– emerging strategies for a definitive treatment13
Editorial overview: Special section neuroimmunology: Neuroimmune interactions in health and disease13
Human inborn errors of immunity to oncogenic viruses13
Editorial overview: Communities in immune cell signaling13
Immunity to EBV as revealed by immunedeficiencies13
Mast cell tryptases in allergic inflammation and immediate hypersensitivity13
Editorial Board13
Harnessing dendritic cell diversity in cancer immunotherapy13
Molecular insights into metabolite antigen recognition by mucosal-associated invariant T cells12
The role of intestinal bacteria in promoting tolerance to food12
Infection and autoinflammation in inborn errors of immunity: brothers in arms12
The tumor-driven antibody-mediated immune response in cancer12
Spontaneous and induced adaptive immune responses in Alzheimer’s disease: new insights into old observations12
Harnessing microglia-based cell therapies for the treatment of neurodegenerative diseases12
Microevolution of Pseudomonas aeruginosa in the airways of people with cystic fibrosis12
Can we cure Sjogren’s disease? Unmet needs and raising questions in the era of Precision medicine12
T follicular helper cells in IgE-mediated pathologies12
From metabolomics to transfusion-associated immunomodulation12
Inflammation induced by lipid mediators and protein from transfusion products12
Innate immune sensing by epithelial barriers12
Spatiotemporal and cell-state control of antigen presentation during tolerance and immunity12
Extracellular vesicle impact on immunity following blood transfusion12
The vicious cycle governing the brain–immune system relationship in neurodegenerative diseases12
Potential immune consequences of cold-stored platelet transfusion11
The role of the antigen processing machinery in the regulation and trafficking of intracellular -Toll-like receptor molecules11
Autoimmune-related adverse events induced by immune checkpoint inhibitors11
Editorial overview: Getting the house in order: Cell-intrinsic mechanisms of innate immune defence11
Friends close, enemies closer: the complex role of the microbiome in antitumor immunity11
Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions11
B-cell antigen presentation in central nervous system autoimmunity11
Multilevel approaches to immunization equity11
Immunotherapy for pemphigus and bullous pemphigoid11
Human guanylate-binding proteins in intracellular pathogen detection, destruction, and host cell death induction10
Autoimmunity, IgE and FcεRI-bearing cells10
Moving beyond the Janus kinase signaling kinases in the pathogenesis and treatment of psoriasis and psoriatic arthritis10
Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus10
The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design10
B cells spatial organization defines their phenotype and function in cancer “Tell me with whom you consort, and I will tell you who you are” ― Goethe10
Structure–function of type I and III interferons10
Fuelling B cells: dynamic regulation of B cell metabolism10
Editorial Board10
In search of the cell biology for self- versus non-self- recognition10
Peptide-dependent tuning of major histocompatibility complex motional properties and the consequences for cellular immunity10
SARS-CoV-2 and chronic kidney disease: challenges and future directions10
Editorial Board10
Carbohydrate metabolism in supporting and regulating neutrophil effector functions9
Major histocompatibility complex class I assembly within endolysosomal pathways9
Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus9
Turning foes into permissive hosts: manipulation of macrophage polarization by intracellular bacteria9
T cell immunity to cytomegalovirus infection9
Chemokines that govern T cell activity in tumors9
Editorial Board9
Next generation immunotherapy: enhancing stemness of polyclonal T cells to improve anti-tumor activity9
The role of interferon in the thymus9
Infections in activated PI3K delta syndrome (APDS)9
Two for the price of one: itaconate and its derivatives as an anti-infective and anti-inflammatory immunometabolite9
Dynamic changes in macrophage metabolism modulate induction and suppression of Type I inflammatory responses9
Insights into the pathogenesis of allergic disease from dedicator of cytokinesis 8 deficiency9
Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines8
Tissue-specific proteasomes in generation of MHC class I peptides and CD8+ T cells8
The role of allergen-specific regulatory T cells in the control of allergic disease8
Metabolic adaptations of ILC2 and Th2 cells in type 2 immunity8
There is no gene for CVID — novel monogenetic causes for primary antibody deficiency8
Cross-reactivity between microbial and tumor antigens8
T-bethighCD21low B cells: the need to unify our understanding of a distinct B cell population in health and disease8
Local and remote interactions between macrophages and microglia in neurological conditions8
Editorial Board8
Editorial overview: Human inborn errors of immunity to infection8
Criteria to make animal studies more relevant to treating human cancer8
Immunological insights in the treatment of chronic hepatitis B8
Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms8
Mechanisms encoding STAT functional diversity for context-specific inflammatory responses8
Editorial Board8
T cell–B cell interactions in human autoimmune diseases7
Regulatory T cells in the context: deciphering the dynamic interplay with the tissue environment7
Nr4a nuclear receptors: markers and modulators of antigen receptor signaling7
Lymphatic messengers: Non-antigen soluble mediators from diseased tissues to draining lymph nodes7
Tipping the balance: innate and adaptive immunity in mitochondrial disease7
New insights into human immunity from ancient genomics7
Advances in genetic–immunological targeted therapies for psoriasis7
Metabolic footprint and logic through the T cell life cycle7
Developments in oral enterotoxigenic Escherichia coli vaccines7
Move and countermove: the integrated stress response in picorna- and coronavirus-infected cells7
Epithelial-immune interactions govern type 2 immunity at barrier surfaces7
Clean up by aisle 2: roles for IL-2 receptors in host defense and tolerance6
Insights into platelet post-transfusional human leukocyte antigen I immunization6
Determinants of persistent Salmonella infections6
Editorial overview: Innate immunity – 2023: Just in time defense6
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects6
Immunological complications of blood transfusion: current insights and advances6
Neuroimmune recognition of allergens6
Editorial Board6
Systems biology approaches to unravel lymphocyte subsets and function6
Stromal cell regulation of inflammatory responses6
Mapping economic outcomes: how biosimilars enhance access to health systems in Latin America and the Caribbean6
Charcot–Leyden crystals and other protein crystals driving type 2 immunity and allergy6
Editorial overview: Autoimmunity 20226
CD1 displays its own negative regulators5
Mitochondrial reactive oxygen species: double agents in Mycobacterium tuberculosis infection5
Nasal vaccines for pertussis5
Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?5
Tripping the wire: sensing of viral protease activity by CARD8 and NLRP1 inflammasomes5
More X’s, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity5
Imaging the T-cell receptor: new approaches, new insights5
Innate immune defenses at the maternal-fetal interface5
Recent progress in understanding of allergic transfusion reaction5
Tissue-resident CD8 T cells in central nervous system inflammatory diseases: present at the crime scene and …guilty5
0.46787786483765